Purchase Order 75N93022P00054

This firm-fixed-price delivery order was awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, to provide COVID-19 reagents. The $318,880 contract has an ultimate completion date of January 21, 2021 and was not set aside for any specific business type. Gen-Probe is an experienced federal contractor, holding numerous contracts with defense and civilian agencies to supply molecular diagnostic testing systems, assays, and related products and services,...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $221,667.07 firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for COVID-19 research library preparation reagent kits. The order includes KAPA HyperExplore MAX 20Mb reagent kits and KAPA Universal Adapter products, to be delivered to the NIH Rocky Mountain Laboratories in Montana. The...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $79,520 firm fixed-price purchase order is for the delivery of two (2) AMMAG SA Magnetic Purification Systems and twenty (20) units of AMMAG Protein A Magnetic Beads. This requirement supports critical COVID-19 research activities at NIAID's...

The Defense Health Agency awarded a $380,520 firm fixed price delivery order contract to Gen-Probe Incorporated on March 24, 2021 to supply COVID-19 reagents. The contract has an anticipated completion date of April 1, 2021 and supports the agency's efforts responding to the Coronavirus Disease 2019 pandemic under the National Interest Action Code for COVID-19. Gen-Probe Sales & Service, Inc. will perform the contract from their place of performance in Marlborough, Massachusetts. No...

This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a for-profit medical diagnostics company, for the provision of COVID-19 reagents. The contract has a ceiling value of $965,100.00 and an ultimate completion date of November 1, 2020. The contract was awarded under the Coronavirus COVID-19 national interest action code and is not set aside. Gen-Probe is a specialized supplier of molecular diagnostic testing systems, assays, and related...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $745,560 firm fixed price purchase order to Biosearch Technologies, Inc., doing business as Biosearch Technologies, to support COVID-19 emergency response efforts. Under this contract, Biosearch Technologies will provide products and services related to coronavirus testing and mitigation from its location in Petaluma, California through June 30, 2021. No subcontractors or set aside...

The Defense Health Agency awarded a $121,840 firm fixed price delivery order contract to Gen-Probe Incorporated, operating through its Gen-Probe Sales & Service, Inc. division, to supply COVID19 reagents. The place of performance is in Marlborough, Massachusetts. The contract supports the agency's response to the Coronavirus COVID-19 national interest and has a completion date of January 26, 2021. No set-aside designation was used for this award to procure reagents in direct support of the...

This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...

This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...